However, since tissue-resident macrophage expansion appears to be a pathological factor in both atherosclerosis and cancer, blockade of monocyte recruitment and the subsequent concomitant increase of the monocyte-attracting protein CCL2 into the diseased tissue, would at least partially contribute to mitigating the disease progression. This evidence concerns the gene CCL2 and cancer.